Research Streams | Psychiatry | School of Medicine

The department has a wide range of research and clinical studies resources. Our research units have well-developed infrastructure to support our studies and well-trained staff that have many years of both clinical and research expertise. We strive to further the promotion and development of research activities and research excellence within the department.

We provide opportunities for research training and support to enable the development of research interests among faculty and residents.

Pen on the word research

Department of Psychiatry Research Streams

Anxiety Disorders and Obsessive Compulsive Disorders

Research Champion

Rafael Freire
Associate Professor
Email: rafael.freire@queensu.ca

This research stream focuses on neurobiology, biomarkers, neurostimulation, and psychopharmacology in anxiety disorders and obsessive-compulsive disorders.

Key researchers in this stream

Elisa Brietzke
Professor, Department of Psychiatry, Queen’s University
elisa.brietzke@queensu.ca

Claudio Soares
Professor, Department of Psychiatry, Queen’s University
c.soares@queensu.ca

Current research projects

Trigeminal nerve stimulation in treatment-resistant generalized anxiety disorder: a feasibility study
PI: Rafael Freire
Co-investigators: Elisa Brietzke and Claudio Soares

Adjunctive Treatment with L-methylfolate for Treatment-Resistant Generalized Anxiety Disorder: a Pilot Study
PI: Rafael Freire
Co-investigators: Elisa Brietzke and Claudio Soares

Cross-Cultural Patterns of Consultation-Liaison Psychiatry Referrals: a Comparison between a Canadian and an Omani Hospital
PI: Rafael Freire
Co-investigators: Elisa Brietzke, Elvina Chu and Claudio Soares

Anxiolytic effects of serotoninergic psychedelics on patients with psychiatric disorders: a systematic review and meta-analysis
PI: Rafael Freire
Co-investigators: Elisa Brietzke

A Phase 2a, Placebo-Controlled Randomized, Double-Blind Trial to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults with Generalized Anxiety Disorder
PI: Claudio Soares
Co-investigators: Rafael Freire

Publication list (last 5 years):

1. Kyriakoulis P, Freire, RCD. Fear Circuits in Panic Disorder: An Update. Alpha Psychiatry 2025; 26(3): 44174. doi: 10.31083/AP44174.

2. Cuyler R, Mojgani JS, Albuquerque da Costa JC, Freire RC. Capnometry-Guided Respiratory Intervention in Veteran PTSD: Impact on Symptom Clusters. Healthcare 2025;13(4):390. doi: 10.3390/healthcare13040390.

3. Kyriakoulis P, Wijaya C, Quagliato L, Freire RC, Nardi AE. Neurocircuitry and Neuroanatomy in Panic Disorder: A Systematic Review. Alpha Psychiatry 2025; 26(1): 38756. https://doi.org/10.31083/AP38756.

4. Marcos Fidry, Morena Mourao Zugliani, Mariana Costa do Cabo, Renan Machado Martins, Manuella Assad Gomez, Clara Gitahy Falcão Faria, Antonio Egidio Nardi, Rafael C Freire. Pharmacogenetic Testing in Treatment-resistant Panic Disorder: a Preliminary Analysis. Clin Pract Epidemiol Ment Health 2024, Dec 3:20:e17450179337258. doi: 10.2174/0117450179337258241031035148. PMID: 39839219 PMCID: PMC11748058.

5. Cabo MC, Costa JCA, Nardi AE, Freire RC. Childhood Separation Anxiety Disorder and Panic Disorder: Differences Between Respiratory and Nonrespiratory Subtypes. Prim Care Companion CNS Disord 2024, 26(5):24m03709. doi: 10.4088/PCC.24m03709. PMID: 39320848.

6. Moraes ACN, Wijaya C, Freire R, Quagliato LA, Nardi AE, Kyriakoulis P. Neurochemical and genetic factors in panic disorder: a systematic review. Transl Psychiatry 2024, 14(1):294. doi: 10.1038/s41398-024-02966-0. PMID: 39025836 PMCID: PMC11258274.

7. Garakani A, Buono FD, Salehi M, Funaro MC, Klimowicz A, Sharma H, Faria CGF, Larkin K, Freire RC. Antipsychotic agents in anxiety disorders: An umbrella review. Acta Psychiatr Scand 2024, 149(4):295-312. doi: 10.1111/acps.13669. PMID: 38382649.

8. Al-Mahrouqi T, Al Alawi M, Freire RC. (2023) Dexmedetomidine in the Treatment of Depression: An Up-to-date Narrative Review. Clin Pract Epidemiol Ment Health.; 19:e174501792307240. doi: 10.2174/17450179-v19-230823-2023-4.

9. Freire RCR, Nardi AE. (2023) Is it possible to prevent relapse in panic disorder? Expert Rev Neurother.; 23(8):677-679. doi: 10.1080/14737175.2023.2229955. Epub 2023 Jun 26.

10. Brietzke E, Gomes FA, Gerchman F, Freire RCR. (2023) Should systematic reviews and meta-analysis include data from preprints? Trends Psychiatry Psychother.;45:1-2. doi: 10.47626/2237-6089-2021-0324. Epub 2021 Sep 8.

11. Faria CGF, de Matos UMA, Llado-Medina L, Pereira-Sanchez V, Freire R, Nardi AE. (2022) Understanding and addressing COVID-19 vaccine hesitancy in low and middle income countries and in people with severe mental illness: Overview and recommendations for Latin America and the Caribbean. Front Psychiatry.;13:910410. doi: 10.3389/fpsyt.2022.910410.

12. Garakani A, Freire RC, Buono FD, Thom RP, Larkin K, Funaro MC, Salehi M, Perez-Rodriguez MM. (2022) An umbrella review on the use of antipsychotics in anxiety disorders: A registered report protocol. PLoS One, Vol. 17(6):e0269772

13. Ferreira-Garcia R, Costa MA, Gonçalves FG, de Nonohay RG, Nardi AE, Freire RCDR, Manfro GG. (2021) Heart rate variability: A biomarker of selective response to mindfulness-based treatment versus fluoxetine in generalized anxiety disorder. J Affect Disord.;295:1087-1092. doi: 10.1016/j.jad.2021.08.121. Epub 2021 Sep 2.

14. Kyriakoulis P, Kyrios M, Nardi AE, Freire RC, Schier M. (2021) The Implications of the Diving Response in Reducing Panic Symptoms. Front Psychiatry.;12:784884. doi: 10.3389/fpsyt.2021.784884.

15. Garakani, A.; Freire, R. C.; Murrough, J. W. (2021). Pharmacotherapy of Anxiety Disorders: Promises and Pitfalls. Front Psychiatry, 12: 662963.

16. Freire, R. C. and V. A. Santos (2021). Features shared between fear of missing out on rewarding experiences (FOMO) and internet gaming disorder. Braz J Psychiatry, 43 (2): 129-130.

17. Zugliani, M.M., Fidry, M., Steffen, R., Lan, C., Brietzke, E., Milev, R., Nardi, A.E. and Freire, R.C. (2021). Clinical effectiveness of non-TMS neurostimulation in depression: Clinical trials from 2010 to 2020. Progress in Neuro-Psychopharmacology and Biological Psychiatry:110:110287. doi: 10.1016/j.pnpbp.2021.110287. Epub 2021 Feb 19.

Research grants (internal and external)

Name of awarding organisation: Faculty of Health Sciences, Queen’s University
Amount in $CAN: 30,000
Duration of funding: 2 years

Name of awarding organisation: Biohaven Pharmaceuticals Inc.
Amount in $CAN: up to 243,000 (deliverable-based invoicing)
Duration of funding: open-ended

Name of awarding organisation: Department of Psychiatry, Queen’s University
Amount in $CAN: 10,000
Duration of funding: 1 year

Current students

Morená Zugliani - Postdoctoral Research

Mariana Cabo - PhD candidate

Juliette Mojgani - Medical Student

Eknoor Thind - Undergraduate Student

Patia Karmiris - Undergraduate Student

Other information

Link to Queen's University Anxiety Research Lab (QAnxiety) - https://qanxiety.ca/

ResearchGate profile: https://www.researchgate.net/profile/Rafael_Freire

Web of Science profile: https://www.webofscience.com/wos/author/record/872338

Scopus: https://www.scopus.com/authid/detail.uri?authorId=34067584800

ORCID: https://orcid.org/0000-0003-3875-4601

Google Scholar: ‪Rafael C R Freire - ‪Google Scholar

Digital Mental Health

Online Psychotherapy Lab

Research Champion

Dr. Nazanin Alavi, MD, FRCPC
Director, Centre for Digital Health Research (CDHR)
Associate Professor, Department of Psychiatry, Queen's University
Kingston Health Sciences Centre and Providence Care Hospital, Kingston, ON, Canada

Email: n.alavitabari@queensu.ca

The Queen’s University Online Psychotherapy Lab (QUOPL) is a leading research and innovation hub focused on advancing access, quality, and personalization of mental healthcare through digital technologies and artificial intelligence. Based at Queen's University in collaboration with Kingston Health Sciences Centre and Providence Care Hospital, QUOPL develops, implements, and evaluates scalable, evidence-based digital mental health solutions.

The lab specializes in therapist-guided, online psychotherapy programs grounded in Cognitive Behavioural Therapy (CBT), Acceptance and Commitment Therapy (ACT), and Dialectical Behaviour Therapy (DBT), targeting a wide range of conditions including depression, anxiety disorders, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), borderline personality disorder, and substance use disorders. These programs are delivered through structured, modular platforms designed to enhance engagement, accessibility, and clinical outcomes.

A core focus of QUOPL is the development and validation of AI-assisted stepped-care models. Using advanced analytics, natural language processing, and patient-reported data, QUOPL’s AI systems support:

Early triage and risk stratification
Personalized treatment recommendations
Dynamic care pathway allocation based on symptom severity and complexity
Ongoing symptom monitoring and outcome prediction

This AI-enabled approach facilitates more efficient allocation of resources, reduces wait times, and ensures that patients receive the right level of care at the right time, ranging from self-guided digital interventions to therapist-supported care and specialized psychiatric services.

QUOPL has demonstrated significant system-level impact, including substantial reductions in outpatient wait times and improved access to mental health services through its integration within clinical programs. The lab is also actively engaged in large-scale collaborations, including partnerships with national and international institutions, to advance AI-driven clinical decision support and digital therapeutics.

In addition to research and clinical implementation, QUOPL plays a key role in training clinicians and researchers in digital psychotherapy and AI applications in mental health, contributing to capacity building and knowledge translation across healthcare systems.

For more information, please visit the QUOPL website. https://www.queensopl.ca/

Forensic Mental Health

Research Champion

Dr. Najat Khalifa, MD, MBChB, FRCPsych, FRCPC
Professor of Psychiatry

Key Researchers

Dr. Andrew Bickle, MBChB, BMedSc, DipMedSc(Dist), LLM(Dist), FRCPsych, FRCPC
Assistant Professor in Forensic Psychiatry
https://psychiatry.queensu.ca/directory/faculty-gft/andrew-bickle

Dr. Rebecca Douglas, Honours BA, PhD, C.Psych
Assistant Professor
https://psychiatry.queensu.ca/directory/faculty-adjunct-1/rebecca-douglas

Dr. Tariq Hassan, MBBS, FRCPsych, FRCPC Psychiatry, FRCPC Forensic
Associate Professor in Forensic Psychiatry
https://psychiatry.queensu.ca/directory/faculty-gft/tariq-hassan

Dr. Zoe Selhi, MD, MA, FRCPC
Assistant Professor
https://psychiatry.queensu.ca/directory/faculty-gft/zoe-selhi

Dr. Christine Rose
Assistant Professor

Recent Research Projects

Non-Invasive Brain Stimulation (NIBS)

The use of combined cognitive training and Anodal Transcranial Direct Current Stimulation (tDCS) to modulate risky decision-making: A double blind Randomized Controlled Trial (PI: Dr. Najat Khalifa with collaborators from Queen’s University).
The use of Anodal Transcranial Direct Current Stimulation (tDCS) to reduce impulsivity and aggression in people with mild intellectual developmental disabilities: A Randomized Controlled Trial (PI: Dr. Najat Khalifa with collaborators from Queen’s University).
The use of non-invasive brain stimulation techniques in people with intellectual developmental disabilities: a systematic review and meta-analysis (PI: Dr. Andrew Bickle with collaborators from Queen’s University).
The use of transcranial Direct Current Stimulation to reduce body weight and food cravings (Dr. Khalifa with collaborators from the University of Nottingham, UK).
The use of co-design in developing cognitive health-related interventions with community-dwelling older adults: a scoping review protocol (Dr. J. C. Rose)

Terrorism and Mental Health

Risk factors for terrorism: an examination of family, childhood and personality risk factors among Iraqi terrorists, murderers and (Dr. Khalifa with collaborators from the George Washington University, USA).
Pathways to terrorism: The role of childhood factors, personality, and ideology (Dr. Khalifa with collaborators from the George Washington University, USA).
Classifying terrorism: A latent class analysis of primary source socio-political and psychological data (Dr. Khalifa with collaborators from the George Washington University, USA).
Distinguishing lone from group actor terrorists: A comparison of attitudes, ideologies, motivations, and risk factors (Dr. Khalifa with collaborators from the George Washington University, USA).
The psychiatric aspects of terrorism: Prevention and rehabilitation (Dr. Hassan and Dr. Khalifa with collaborators from Queen’s University).
Terrorism Typologies and implications for clinical practice in psychiatry (Dr. Khalifa and Dr. Hassan with collaborators from Queen’s University).
Psychiatric assessment of terror subjects and those at risk of engaging in acts of terrorism (Dr. Khalifa and Dr. Hassan with collaborators from Queen’s University).

Forensic Mental Health

Patient characteristics, outcome measurement and predictors of treatment completion in a community justice and mental health (At-Risk) program in Kingston (PI: Dr. Tariq Hassan with collaborators from Queen’s University).
Traumatic Brain Injury in Criminal Justice Systems: A Systematic Literature Review (PI: Dr. Andrew Bickle with collaborators from Queen’s University).

Program Development/Evaluation

Grading Risk of Inpatient Threat (GRIT)
GRIT is an assessment, communication, and risk management system for the imminent (within 24 hours) risk of inpatient violence. It has been designed for use on the Forensic Services Inpatient Unit at Providence Care, based on current research on imminent risk for violence, practices at other forensic facilities, and current legislative requirements. GRIT will shortly be pilot tested on Forensic Services; an adapted version of the GRIT system will later be implemented on other inpatient units at Providence Care Mental Health Services. The GRIT system will be formally evaluated for effectiveness in reduction of inpatient violence. In addition, data from the project may be combined with data from similar implementations at other forensic sites, as part of a larger scale multi-site research project.

Project Lead/Primary Investigator: Dr. Rebecca Douglas
Collaborators: Kim Knight, RN; Dr. Tariq Hassan

SAFEWARDS implemented on forensic units to improve inpatient safety
The model of care in the Forensic Inpatient Service at Providence Care Hospital incorporates the key components of the Safewards Model, namely originating domains, flashpoints, conflict, and containment. Originating domains are those six broad aspects that affect a patient’s well-being: patient community, patient characteristics, the regulatory framework, the staff team, the physical environment, and external factors (e.g., visitors). The flashpoints are social situations, behaviours, or ways of thinking arising from those originating domains that can trigger a conflict. Conflict is defined as any action or behaviour that can threaten the safety of a patient and those around them. Containment entails actions that staff must take in order to eliminate or reduce conflict.

Sources of Research Funding

Department of Psychiatry

Recent Publications

Medical Education Scholarship and Research

This research stream focuses on research and scholarship in medical education.

Research Champion:

Dr. Maria Hussain, MD FRCPC (Psychiatry and Geriatric Psychiatry)
Associate Professor, Department of Psychiatry, Queen’s University
Contact: mh144@queensu.ca
Google Scholar

Grants, Projects, and Publications:

1. Leveraging Simulation to Increase Competence in Assessment of Capacity in Psychiatry and Geriatric Psychiatry Training. PI: Hussain M; Co-Is: Andrew M, Kirkham, J, Nemiroff L, O'Brien S, St. Denis E, Braund H.
Funded by the SEAMO Endowed Scholarship and Education Fund

2. Operationalizing subspecialty training in the Competence by Design model: A case study of lived experiences PI: Hussain, M, Co-Is: Andrew M; Dejong P; Marcotte L; Delgarno N; Braund H.
Funded by the SEAMO Endowed Scholarship and Education Fund

3. A Realist, Multi-Site Comparison of Competence Committee Implementation Practices. Acai A, Hanmore T, Andrew M, Askari S, Hussain M, Sonnadara R, Trier J. A Realist, Multi-Site Comparison of Competence Committee Implementation Practices.

4. Early lessons in operationalizing Competence Committees: A conceptual framework for decision-making. PI: Trier, J; Co-Is: Hanmore T, Dare J, Andrew M, Askari S, Hussain, M.
Funded by the SEAMO Endowed Scholarship and Education Fund

5. Refining Entrustable Professional Activities in Geriatric Psychiatry Subspecialty Training. PI: Melissa Andrew; Co-Is: Hussain M, Egan R
Funded by the Department of Psychiatry

6. Developing an Entrustable Professional Activity for the Evaluation of a Geriatric Psychiatry Subspecialty Resident’s Ability to Perform a Capacity Assessment. PI: St. Denis E, Co-Is Andrew M, Hussain M

7. Implementing a Transition to Practice Curriculum for Psychiatry and its Subspecialties Informed by Lived Experiences of Queen’s University Graduates. Hussain M (PI), Braund H, Hanmore T, Prost E, Sapru A, Pipitone J. Funding: Queen’s University PGME Special Purpose Grant

Resident Projects in Medical Education Research:

1. Exploring advantages and pitfalls of implementing CBME in geriatric psychiatry. Huynh, D. (geriatric psychiatry resident); supervisor Hussain M.

2. Teaching the skill of effective handover to Psychiatry residents during transitions in care for older adults. Nimrit Bath (geriatric psychiatry resident); supervisor Hussain M.
Funding from the Department of Psychiatry

3. Using simulation to teach assessments of capacity to psychiatry residents. Jonathan Pipitone (psychiatry resident); supervisor Hussain M.

4. Use of large language models in psychiatry residency education. Thusanth Jogarajah, (psychiatry resident); supervisor Hussain M.

Key Researchers:

Dr. Melissa Andrew

Mood Disorders

Research Champion

Professor Gustavo Vazquez
Email g.vazquez@queensu.ca

Peer review publications (2020-2025) *

Tondo L, Vazquez GH, Baldessarini R. Suicidal behavior associated with mixed features in major mood disorders. Psychiatric Clinics of North America 2020; 43:83–93.

Baldessarini R, Vazquez GH, Tondo L. Bipolar Depression: A Major Unsolved Challenge. International Journal of Bipolar Disorders 2020, 8(1).1.

Pompili M, Vazquez GH, Forte A, Morrissette DA, Stahl S. Pharmacological Treatment of Mixed States. Psychiatric Clinics of North America 2020; 43(1):167–186.

Tondo L, Vazquez GH, Baldessarini R. Melancholic vs Nonmelancholic Major Depression Compared. Journal of Affective Disorders 2020, 266:760-765.

Sani G, Tondo L, Undurraga J, Vazquez GH, Salvatore P, Baldessarini RJ. Melancholia: Does this ancient concept have contemporary utility?. International Review of Psychiatry 2020; 32: 466-470.

Kang MJY., Kulcar E., Chandrasena R., Anjum M-R., Fairbairn J., Hawken ER., Vazquez GH. Low Dose Ketamine Infusions for Suicide Ideation Among Patients with Bipolar and Unipolar Treatment Refractory Depression: An Open-Label Clinical Study. Psychiatry Research 2021; 296, 113645.

Phillips , Jaworska N., Kamler E., Bhat V., Blier J., Foster JA., Giacobbe P. Hassel S., Ho K., McMurray L., Milev R., Moazamigoudarzi Z., Placenza FM., Richard-Devantoy S., Rotzinger S., Turecki G., Vazquez GH., Kennedy S, Blier P. A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian Biomarker Integration Network in Depression (CAN-BIND) study protocol. BMC Psychiatry 2020, 20(1):268.

Grigolon RB, Gerchman F, Schöffel AC, Hawken ER, Gill H, Vazquez GH, Mansur RB, McIntyre RS, Brietzke E. Mental, Emotional, and Behavioral Effects of Ketogenic Diet for Non-Epileptic Neuropsychiatric Conditions. Progress in Neuropsychopharmacology & Biological Psychiatry 2020, 102:109947.

Bahji A, Ermacora D, Stephenson C, Hawken E, Vazquez GH. Comparative efficacy and tolerability of pharmacological treatments for the treatment of acute bipolar depression: a systematic review and network meta-analysis. Journal of Affective Disorders 2020, 269:154-184.

Bahji A, Vazquez GH, Zarate C. Comparative efficacy of ketamine and esketamine for depression in randomized controlled trials: a systematic review and meta-analysis. Journal of Affective Disorders 2021; 278:542-555.

Undurraga J, Vazquez GH, Tondo L, Baldessarini RJ. Antidepressant Responses in Head-to-Head Comparisons of Melancholic and Nonmelancholic Depression. Journal of Psychopharmacology 2020; 34(12):1335-1341

Bahji A, Vazquez GH, Zarate CA Jr. Response to commentary on the comparative efficacy of esketamine vs. ketamine meta-analysis: Putting the cart before the horse? J Affect Disord. 2021; 282:258-260.

Téllez JZ, Ortiz HO, Casián LQ, Palars CB, Muñoz MD, Vázquez GH. Validation study of the Spanish brief version of TEMPS-A. Rev Psiquiatr Salud Ment (Engl Ed). 2021:S1888-9891(21)00097-5.

Serafini G, Vazquez GH, Monacelli F, Pardini M, Pompili M, Amore M. The use of antidepressant medications for bipolar I and II disorders. Psychiatry Research 2021, 296, 113273.

Bahji A, Ermacora D, Stephenson C, Hawken, E, Vazquez G. Comparative efficacy and tolerability of adjunctive pharmacological treatments for the treatment of acute bipolar depression: a systematic review and network meta-analysis. Canadian Journal of Psychiatry 2021; 66(3) 274-288.

Tondo L, Vazquez G, Baldessarini RJ. Prevention of Suicidal Behavior in Bipolar Disorder. Bipolar Disorders 2021; 23:14–23.

Corrales A, Cetkovich-Bakmas M, Corral R, Garcia Bonetto G, Herbst L, Lupo C, Morra C, Mosca D, Strejilevich S, Vilaprino JJ, Vilaprino M, Vazquez G. Argentine Consensus on the Diagnosis and Therapeutics of Treatment Resistant Depression (TRD). Vertex 2020; 31:1-40.

Baldessarini R, Tondo L, Vazquez G. Lithium Treatment for Bipolar Disorder. Bipolar Disorders 2021; 23:93–94.

Piskorz D, Puente Barragán A, López Santi R, Vázquez G, Solache Ortiz G, Ramírez Zambrano L, Méndez Castillo M, Márquez Murillo M, Roa C, Baños Mirecly M, Ramos G, Luz Cabral, Sánchez P, Spitz B, Pérez G, López Santi MP, Estrella J, Velarde González M, Rafael Horna E, Baranchuk A. Impact of the Covid-19 pandemic on patients with cardiometabolic diseases in Latin America. The CorCOVID Latam Psy Study. Current Problems in Cardiology 2021; 46(4):100737

Kupka R, Duffy A, Scott, J, Almeida, Balanza-Martinez V, Birmaher B, Bond D, Brietzke E, Chendo I, Frey B, Grande I, Hafeman D, Hajek T, Hillegers M, Kauer-Sant'Anna M, Mansur R, van der Markt A, Post R, Tohen M, Tremain H, Vazquez G, Vieta E, Yatham L, Berk M, Alda M, Kapczinski F. Consensus on nomenclature for clinical staging models in bipolar disorder: A narrative review from the International Society for Bipolar Disorders (ISBD) Staging Task Force. Bipolar Disorders 2021; 23:659–678.

Bahji A, Vazquez G, Zarate C Jr. Response to commentary on the comparative efficacy of esketamine vs. ketamine meta-analysis: Putting the cart before the horse? Journal of Affective Disorders 2021; 282:258-260

Tondo L, Vazquez G, Baldessarini RJ. Melancholia as a DSM-5 specifier or a separate category? Journal of Affective Disorders 2021; 282:39-40

Vazquez G, Bahji A, Undurraga J, Tondo L, Baldessarini RJ. Efficacy and Tolerability of Combination Treatments for Major Depression: Antidepressants plus Second-Generation Antipsychotics vs. Esketamine vs. Lithium. Journal of Psychopharmacology 2021, 35(8):890-900

Bahji A, Danilewitz M, Vazquez G, Patten S. The prevalence of cannabis use disorder comorbidity in individuals with bipolar disorder: a systematic review and meta-analysis. Canadian Journal of Addiction 2021;12(3):22-38.

Sani G, Perugi G, Vazquez G, Tondo L. Transitions: Hagop Souren Akiskal. Journal Affective Disorders 2021; 284: 201-202

Tondo L, Vazquez G, Baldessarini R. Melancholia as a DSM-5 specifier or a separate category? Correspondence. Journal Affective Disorders 2021; 284: 201-202

Yee C, Vazquez G, Hawken E, Biorac A, Tondo L, Baldessarini R. Long-Term Treatment of Bipolar Disorder with Valproate: Updated Systematic Review and Meta-analyses. Harvard Review of Psychiatry 2021: 29(3): 188-195

Bahji A, Zarate Jr. C, Vazquez G. Ketamine for bipolar depression: a systematic review. International Journal of Neuropsychopharmacology 2021; 24(7):535-541

Kang M, Vazquez G. A Pilot Study: An Open-Label Biomarker Development of Ketamine for Unipolar Treatment-Resistant Depression. Biological Psychiatry 2021; 89(9): 92-93.

Guzzo E, Kupritzki H, Agranatti A, Smith J, Larre N, Rozic P, Vieta E, Vazquez G, Vinacur C. Evaluation of the functionality and subjective well-being of bipolar patients with the Functioning Assessment Short Test (FAST) and the World Health Organization - Five Well- Being Index (WHO-5). Vertex 2022; 33(156):16-24

Philipp-Muller A, Reshetukha T, Vazquez G, Milev R, Armstrong D, Jagayat J, Alavi N. Combined Ketamine and Online CBT for the Treatment of Post Traumatic Stress Disorder (PTSD). JMIR Res Protocols 2021; 10(7):e30334

Yee C, Bahji A, Lolich M, Vazquez G, Baldessarini R. Comparative efficacy and tolerability of antipsychotics for juvenile psychotic disorders: a systematic review and network meta-analysis. J Clin Psychopharm 2022; 42(2):198–208.

Meyyappan A, Sgarbossa C, Vazquez G, Bond D, Muller D, Milev R The Safety and Efficacy of Microbial Ecosystem Therapeutic-2 in People With Major Depression: Protocol for a Phase 2, Double-Blind, Placebo-Controlled Study. JMIR Res Protoc 2021;10(9):e31439

Baldessarini R, Pinna M, Cunto M, Vazquez G, Tondo L, Risk Factors for Early Recurrence After Discontinuing Lithium in Bipolar Disorder. Bipolar Disorder 2022;24(7):720-725.

Yatham L, Chakrabarty T, Bond D, Schaffer A, Beaulieu S, Parikh S, McIntyre R, Milev R, Alda M, Vazquez G, Ravindran A, Frey B, Sharma V, Goldstein B, Rej S, O’Donovan C, Tourjman V, Kozicky J-M, Kauer-Sant’Anna M, Malhi G, Suppes T, Vieta E, Kapczinski F, Kanba S, Lam R, Kennedy S, Calabrese J, Berk M, Post R. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations. Bipolar Disord. 2021 (8):767-788

Similon M, Paasche C, Krol F, Lerer B, Goodwin GM, Berk M, Meyer-Lindenberg A, Ketter TA, Yatham LN, Goldberg JF, Malhi GS, El-Mallakh R, Licht RW, Young AH Kapczinski F, Swartz M, Hagin M, Torrent C, Serretti A, Yildiz A, Martínez-Arán A, Strejilevich S, Rybakowski J, Sani G, Grunze H, Vázquez G, Gonzales Pinto A, Azorin JM, Nolen W, Sentissi O, López-Jaramillo C, Frey BN, Nierenberg A, Parker G, Bond DJ, Cohen A, Tortorella A, Perugi G, Vieta E, Popovic D. Expert Consensus Recommendations on the Use of Randomized Clinical Trials for Drug Approval in Psychiatry. European Neuropsychopharmacology 2022, (7) 91-99

Bahji A, Zarate C Jr, Vazquez G. Efficacy and safety of racemic and esketamine for depression: a systematic review and meta-analysis. Expert Opinion on Drug Safety 2022; 21:6, 853-866.

Cetkovich-Bakmas M, Abadi A, Camino S, Garcia Bonetto G, Herbst L, Marengo E, Torrente F, Maresca T, Bustin J, Morra C, Corral R, Sotelo D, Strejilevich S, Pessio J, Vilaprino JJ, Vilaprino M, Vazquez G Corrales A,. 3rd Argentine Consensus Statement on Management of Bipolar Disorders. Section I: Introduction and General Concepts. Vertex Rev Arg Psych 2022; 33(158) 56-88.

Gutierrez G, Rosenblat J, Hawken E, Swainson J, Vazquez G. Efficacy and Tolerability of Two Novel "Standard of Care" Treatments-Intranasal Esketamine Versus Intravenous Ketamine-for Treatment-Resistant Depression in Naturalistic Clinical Practice: Protocol for a Pilot Observational Study. JMIR Res Protoc. 2022;11(5):e34711

Torrente F, Yoris A, Low D, Lopez P, Bekinschtein P, Vazquez G, Manes F, Cetkovich M. Psychological symptoms, mental fatigue and behavioural adherence after 72 continuous days of strict lockdown during the COVID-19 pandemic in Argentina. British Journal of Psychiatry Open 2022, (8)e10:1-9

Kang M, Hawken E, Vazquez G. The Mechanisms Behind Rapid Antidepressant Effects of Ketamine: A Systematic Review with a Focus on Molecular Neuroplasticity. Frontiers in Psychiatry 2022, 25;13:860882.

Vazquez G, Gutierrez G, Rosenblat J, Schaffer A, Swainson J, Karthikeyan G, Ravindran N, Lam R, Do A, Giacobbe P, Hawken E, Milev R. Association of intranasal esketamine, a novel ‘standard of care’ treatment and outcomes in the management of patients with treatment-resistant depression. Protocol of a prospective cohort observational study of naturalistic clinical practice. British Journal of Psychiatry Open 2022, 12:e060967.

Garcia-Zamora S, Pulido L, Miranda-Arboleda AF, Garcia DE, Perez G, Priotti M, Chango DX, Antoniolli M, Zaidel EJ, Lopez-Santi R, Vazquez G, Nuñez-Mendez R, Cabral LT, Sosa-Liprandi A, Liblik K, Baranchuk A. Aggression, micro-aggression, and abuse against Health Care Providers during the COVID-19 pandemic. A Latin American Survey. Curr Probl Cardiol. 2022; 29:101296

Corral R, Bojorquez E, Cetkovich-Bakmas M, Cordoba R, Chestaro J, Gama C García Bonetto G , López Jaramillo C, Moreno RA, Ng B, Pena de Leon E, Risco L, Silva H, Vazquez G. Latin American Consensus Recommendations for the Management and Treatment of Patients with Treatment Resistant Depression (TRD). Jour Psych and Ment Health 2023, :S2950-2853(23)00013-3.

Gutierrez G and Vazquez GH. Pros and cons of esketamine treatment in Psychiatry. European Neuropsychopharmacology. 2022; 65:12-14

Kang M, Vazquez GH. Association between peripheral biomarkers and clinical response to IV ketamine for unipolar treatment-resistant depression: An open label study. Journal of Affective Disorders, 2022; 318:331-337

Philipp-Muller A, Reshetukha T, Vazquez G, Milev R, Armstrong D, Jagayat J, Alavi N. Combining ketamine and psychotherapy for the treatment of post traumatic stress disorder: a systematic review and meta-analysis. Journal of Clinical Psychiatry 2023;84(2):22br14564.

Tondo L, Vázquez GH, Baldessarini RJ. Commentary on Australian recommendations on treatment of bipolar and major depressive disorders. Bipolar Disord 2024; in press

Baldessarini RJ, Vázquez GH. The rise and fall of the age of psychopharmacology. J Clin Psychopharmacol 2022; 42(4):340–342

Bahji A, Vazquez GH, Zarate CA Jr. Response to "Letter to the Editor: Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis.". J Affect Disord. 2023; 324:68.

Hernandorena C, Baldessarini R, Tondo L, Vazquez G. Current status of type II vs. type I bipolar disorder: systematic review with meta-analyses. Harvard Review of Psychiatry 2023; 31(4):173-182

Gutierrez G, Stephenson C, Eadie J, Moghimi E, Omrani M, Groll D, Soares C, Milev R, Vazquez G, Yang M, Alavi N. Evaluating the efficacy of Web-Based Cognitive Behavioural Therapy for the treatment of patients with Bipolar II Disorder and residual depressive symptoms: Protocol for a randomized controlled trial. JMIR Research Protocols 2023; 12:e46157

Vazquez G & Baldessarini RJ. Ketamine infusions for treatment-resistant bipolar depression: Commentary. Bipolar Disorders 2023; 25:431-432

Noyes B, Biorac A, Vazquez G, Khalid-Khan S, Munoz D, Booij L. Eye-tracking in adult depression: protocol for a systematic review and meta-analysis. Brit Med Journ Open 2023; 13:e069256.

Gutierrez G, Kang MJY, Vazquez G. Low dose ketamine infusions for treatment resistant depression: real world efficacy and safety in a clinical practice sample. Psychiatry Research 2024, 335:115865.

Cetkovich-Bakmas M, Abadi A, Camino S, Garcia Bonetto G, Herbst L, Marengo E, Torrente F, Maresca T, Bustin J, Morra C, Corral R, Sotelo D, Strejilevich S, Pessio J, Vilaprino JJ, Vilaprino M, Vazquez G, Corrales A. 3rd Argentine Consensus Statement on Management of Bipolar Disorders. Section 2 A: Comprehensive treatment of bipolar disorders in Adults. Vertex Rev Arg Psych 2023; 34(159) 47-70.

Hernandorena C., Gutierrez G, Cabrera Abreu C, Vazquez G. Biweekly vs Triweekly low dose intravenous ketamine acute series for severe major depression: A case report. Journal of Affective Disorders Reports. 2023; 14:100620

Gutierrez G, Gizzarelli T, Moghimi E, Vazquez G, Alavi N. Online cognitive behavioral therapy (eCBT) for the management of depression symptoms in unipolar and bipolar spectrum disorders, a systematic review and network meta-analysis. Journal of Affective Disorders 2023; 341, 37-39.

Sgarbossa C, Chinna Meyyappan A, Forth E, Bromley H, Vazquez G, Milev R. A longitudinal follow-up of microbe therapy as treatment for psychiatric disorders: a systematic review. Human Microbiome Journal 2024 (in press)

Parodi J, Burgos LM, Garcia-Zamora S, Liblik K, Pulido L, Gupta S, Saldarriaga C, Puente-Barragan AC, Morejón-Barragán P, Alexanderson-Rosas E, Sosa-Liprandi A, Botto F, Sosa-Liprandi MI, Lopez-Santi R, Vazquez G, Gulati M, Baranchuk A. Gender differences in workplace violence against physicians and nurses in Latin-America. A survey from the Interamerican Society of Cardiology. Public Health 2023; 225:127-132.

Nikolin S, Rodgers A, Schwaab A, Bahji A, Zarate C, Vazquez G, Loo C. Ketamine for the treatment of major depression: a systematic review and meta-analysis. Eclinicalmedicine. The Lancet 2023, Vol 62, 102127

Garcia-Zamora S, Iomini PA, Pulido L, Miranda-Arboleda AF, Lopez-Santi P, Burgos LM, Perez GE, Priotti M, García DE, Antoniolli M, Musso G, Zaidel EJ, Sosa-Liprandi A, Vazquez G, Lopez-Santi R, Del-Sueldo MA, Baranchuk A. Violence and aggressions towards health care workers in Argentina during the COVID-19 pandemic: Sub-study of the SIAC violence survey. Rev Per Medic Exp y Salud Publica 40(2); 2023

Cetkovich-Bakmas M, Abadi A, Camino S, Garcia Bonetto G, Herbst L, Marengo E, Torrente F, Maresca T, Bustin J, Morra C, Corral R, Sotelo D, Strejilevich S, Pessio J, Vilaprino JJ, Vilaprino M, Vazquez G Corrales A. 3rd Argentine Consensus Statement on Management of Bipolar Disorders. Section 2 B: Comprehensive treatment of bipolar disorders in Adults. Vertex Rev Arg Psych 2023; 34(160) 24-52.

Cetkovich-Bakmas M, Abadi A, Camino S, Garcia Bonetto G, Herbst L, Marengo E, Torrente F, Maresca T, Bustin J, Morra C, Corral R, Sotelo D, Strejilevich S, Pessio J, Vilaprino JJ, Vilaprino M, Vazquez G Corrales A. 3rd Argentine Consensus Statement on Management of Bipolar Disorders. Section 3: Management of bipolar disorders in special populations. Vertex Rev Arg Psych 2023; 34(161) 87-110.

Lunsky I, Gutierrez G, Bahji A, Vazquez G. Efficacy and Safety of Four Psychedelic-Assisted Therapies for Adults with Symptoms of Depression, Anxiety, and Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis. J Psychoactive Drugs 2023 1-16 https://doi.org/10.1080/02791072.2023.2278586.

Daray F, Grendas LN, Arena A, Tifner V, Álvarez Casiani R, Olaviaga A, Chiapella L, Vázquez G, Penna MB, Hunter F, Prokopez C, Carrera Silva E, Errasti A. Decoding the inflammatory signature of the major depressive episode: Insights from peripheral immunophenotyping in active and remitted condition. Translational Psychiatry 2024,14:254

Hernandorena C, Dines M, Miola A, Baldessarini R, Tondo L, Vazquez G. Clinical Prescription of Lithium, Anticonvulsants Antipsychotics, and Antidepressants for Major Mood Disorders. International Journal of Bipolar Disorders 2025, 13(1):24. doi: 10.1186/s40345-025-00381-y

Hernandorena C, Gutierrez G, Vazquez G. Burn out in health care workers in Latin America. Journal of the Inter American Society of Cardiology (SIAC), Vol 1(1)2-4, 2023

Chinna Meyyappan, A., Bromley, H., Sgarbossa, C., Forth, E., Müller, D. J., Vazquez, G., Cabrera, C., Milev, R. The Safety and Efficacy of Microbial Ecosystem Therapeutic-2 in People with Major Depression – A Phase 2, Double-Blind, Placebo- Controlled Study: Clinical Results. Canadian Journal of Psychiatry 2025, 70(11):816-823 https://doi.org/10.1177/070674372513282

Corrales A., Cetkovich-Bakmas M., Abadi A., Camino S., García Bonetto G., Márquez Lopez Mato A., Marengo E., Abraham E., Maresca T., Bagnati P., Dallamea A., Canseco D., Morra C., Corral R., Sotelo D., Strejilevich S., Pessio J., Vilapriño J.J., Vilapriño M., Rebok F., Vazquez G. Update on the use and management of lithium in neuropsychiatry. Vertex Rev Arg Psych 2023; 34(162): 38-82.

Lam R, Kennedy S, Adams C, Bahji A, Beaulieu S, Bhat V, Blier P, Blumberger D, Brietzke E, Chakrabarty T, Do A, Frey B, Giacobbe P, Gratzer D, Grigoriadis S, Habert J, Husain I, Ismail Z, McGirr A, McIntyre R, Michalak E, Müller D, Parikh S, Quilty L, Ravindran A, Ravindran N, Renaud J, Rosenblat J, Samaan Z, Saraf G, Schade K, Schaffer A, Sinyor M, Soares C, Swainson J, Taylor V, Tourjman S, Uher R, van Ameringen M, Vazquez G, Vigod S, Voineskos D, Yatham L, Milev R. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults. Canadian Journal of Psychiatry 20204. May 6:7067437241245384. doi: 10.1177/07067437241245384

Nuñez N, Boney J, Vazquez G. Old Treatments New Outcomes-Latest Augmentation Treatments for Depression. Frontiers in Psychiatry 2024, 15:1384641.

Gutierrez G, Swainson J, Ravindran N, Lam RW, Giacobbe P, Karthikeyan G, Kowara A, Do A, Baskaran A, Nestor SM, Kang MJY, Biorac A, Vazquez G. IN Esketamine and IV Ketamine: Results of a multi-site observational study assessing the effectiveness and tolerability of two novel therapies for treatment-resistant depression. Psychiatry Research 2024 Oct;340:116125

Grasso V, Gutierrez G, Alzbeidi N, Hernandorena C, Vázquez G. Cognitive performance in patients with major depressive disorder treated with IV ketamine: A systematic review of the literature. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2024;135:111095.

Abadi A, Cetkovich-Bakmas M, Klijnan H, Echavarria N, Lischinsky A, Lopez P, Michanie C, Maresca T, Remedi C, Rovere O, Torrente F, Waisman Campos M, Maraval G, Torralva T, Canseco D, Dellamea A, Lopez Mato A, Vazquez G, Corrales A. First Argentine Consensus on the Management of Attention Deficit Hyperactivity Disorder in Adulthood. Vertex Rev Arg Psych 2024; 35(166):67-105

Baldessarini RJ, Miola A, Vázquez G, Tondo L. Responses to clinical treatment of bipolar versus unipolar depressive episodes in women versus men. Journal of Psychopharmacology 2025; 39(2):171-175.
Vazquez G, Baldessarini RJ. Antidepressants in the Treatment of Bipolar Depression: Commentary. International Journal of Neuropsychopharmacology 2025 28(3):pyaf013. doi: 10.1093/ijnp/pyaf013.

Sotelo D, Grasso V, Dines M, Hofmann B, Vázquez G, Cetkovich-Bakmas M. Controversies of mixed states in bipolar disorder: From Wilhelm Weygandt's contributions to DSM-5 classifications. Vertex Rev Arg Psych 2025; 36(167):56-66

Vázquez G. Low dose IV Ketamine therapy for treatment-resistant major depression. Letter to the editor. Vertex Rev Arg Psych 2025; 36(167):116-117

Dillon C, Peralta CM, Driollet Laspiur S, Barisic M, Cupito A, de Jauregui M, Bellotto M, Romano M, Perez Leguizamon P, Castro D, Garcia V, Maggi S, Viaggio MB, Vazquez G. Utility of a Comprehensive Neuropsychiatric and Neuropsychological Evaluation for Assessing Patients with Parkinson's Disease Selected for Deep Brain Stimulation Surgery. Brain Sciences 2025 (in press)

Dines M, Bulacia, Bamondez P, Luis Vega I, Montenegro M, Diaz PG, Oyhamburu P, Ramos AL, Ambrosio F, Vazquez G. Subanesthetic Dose Ketamine Infusions for Treatment-Resistant Major Depression: An Application Protocol at a Public Hospital in Argentina. Vertex Rev Arg Psych 2025; 36(168):33-38.

Gutierrez G, Vazquez G, Ravindran N, Lam R, Giacobbe P, Karthikeyan G, Kowara A, Do A, Baskaran A, Nestor SM, Swainson J. Abuse Liability for Esketamine in a cohort of patients undergoing an acute treatment course to manage treatment-resistant depression: secondary analysis of an observational study in real world clinical practice. Therapeutic Advances in Drug Safety. 2025;16. doi:1177/20420986251347360

Dines M, Bulacia A, Bamondez P, Irene L, Montenegro M, Diaz P, Oyhamburu P, Ramos A, Ambrosio F, Vazquez G. Ketamine Infusions for Treatment-Resistant Depression: A Case Report of a Patient Treated in a Public Hospital in Argentina. Innovation in Clinical Neurosciences 2025 (in press)

Gupta K, Kaminska M, Gupta S, Waraich H, Malik S, Meghdadi A, Marcotte L, Vazquez GH, Baranchuk A. The Psychological Impact of Implantable Cardioverter Defibrillators: A Narrative Review. American Journal of Cardiology 2025, 255:83-88. doi: 10.1016/j.amjcard.2025.07.007. Epub ahead of print. PMID: 40659282.

Grasso V, Cabrera-Abreu C, Vazquez G. (2025). The importance of identifying major depressive disorder with mixed symptoms in primary care. Journal of Evidence in Primary Care 28(4), e007186. https://doi.org/10.51987/evidence.v29i1.7186

Strejilevich S, Sotelo D, Grasso V, Alonso J, Garcia Bonetto G, Corrales A, Strejilevich F, Vazquez G, Zarate CA Jr. Ketamine Infusions for Treatment-Resistant Mood Episodes: Insights from Users in Long-Term Naturalistic Treatment. Neuroscience Applies 2026; (5)1:106240 https://doi.org/10.1016/j.nsa.2025.106240

Algarni A, Vazquez G, Alotibi T, Hernandorena C, Knyahnytska K. Efficacy and Safety of Ketamine Maintenance Therapy in Treatment-Resistant Depression: A Systematic Review of Treatment Protocols and Clinical Outcomes. Journal of Affective Disorders 394; 2026 /doi.org/10.1016/j.jad.2025.120475

Alzbeidi N, Avila Christian, Cabrera Abreu C, Kolar D, Milev R, Jokic R, Knyahnytska Y, Vazquez G. Comparative Analysis of Stimulant and Non-Stimulant Treatment Groups in a Mood Disorders Outpatient. Journal of Attentional Disorders 2025 (in press)

Cabrera Abreu C, Biorac A, Baldessarini RJ, Vázquez G. From model psychosis to rapid antidepressant: a historical and conceptual review of ketamine’s psychiatric history. Therapeutic Advances in Psychopharmacology 2025. (15);1-12 doi:1177/20451253251392429

Dines, M, Hernandorena, C, Grasso, V, Vazquez, G. Critical Overview of Screening Tools for Detecting Bipolar Disorders. Actas Españolas De Psiquiatría, 2025, 53(5), 1122–1130. https://doi.org/10.62641/aep.v53i5.1924

Cabrera-Abreu C, Alzbeidi N, Avila C, Hernandorena C, Kolar D, Milev R, Jokic R, Knyahnytska Y, Vazquez GH. Identifying Clinical Markers of Bipolar Disorder in a Depressed Outpatient Sample: A Tertiary Clinic Comparison with Major Depression Disorder. Journal Affective Disorders 2026; 394:120612

Vazquez G, Hernandorena C, Alzbeidi N, Avila C, Cabrera-Abreu C, Baldessarini RJ. Clinical Staging for Mood Disorders in a Tertiary Care Population: A Dimensional Approach to Illness Severity. Early Intervention in Psychiatry 2025 (in press).

Vazquez G, Alzbeidi N, Kolar D, Cabrera-Abreu C. Identifying Suicide Risk in Mood Disorders: A Multivariate Analysis from a Specialized Clinic. Journal Affective Disorders 2026; 399:121140. doi: 10.1016/j.jad.2025.121140

De Prisco M, Oliva V, Miola A, Fornaro M, Dragioti E, Croatto G, Carvalho AF, Berk M, Nikolitch K, Saraf G, Yatham L, Keramatian K, Shorr R, Frye M, Singh B, Krinitski D, Højlund M, Serretti A, Fanelli G, Gomes FA, Hansen AS, Nielsen RE, Fusar-Poli P, Paribello P, Manchia M, Bahji A, Vazquez G, Siafis S, Leucht S, Yildiz A, Delorme R, Schaffer A, Stubbs B, Rubaiyat R, Vieta E, Correll CU, Moher D, Cortese S, Radua J, Fiedorowicz JG, Gosling C, Solmi M. Evidence-based interventions for bipolar disorder (EBI-BD): an Umbrella-Review, Evaluation, Analysis, and Communication Hub (U-REACH) project in bipolar disorder across phases and age groups. BMJ Psychiatry 2025 (in press)

Swainson J, Lunsky I, Gutierrez G, Wang X, Zhuang A, Zhang Y, Vazquez G, Bhat V, Archer S, Khullar A, Chrenek C. Ketamine and Esketamine for Postpartum depression: A systematic review and network meta-analysis. Journal Affective Disorders 2025 (in press).

Vazquez G, Grasso V, Dines M, Hernandorena M, Sotelo D, Hofmann B, Cetkovich-Bakmas M. Mixed Symptoms in Mood Disorders: A Historical, Clinical and Therapeutic Review. Vertex Rev Arg Psych 2025; 36(170): 75-83

Corrales A, Abadi A, Bartoli G, Benavente Pinto C, Cabrera A, Camino S, Corral R, Delmonte G, García Bonetto G, Garay CJ, Gargoloff D, Gargoloff P, Goldchluk A, Iveli MF, Jufe G, Lamaison F, Leiderman E, López Mato A, Marengo E, Maresca T, Michat MD, Morra C, Prokopez C, Ramírez J, Rebok F, Rubio Domínguez E, Sotelo D, Strejilevich S, Toro Martínez E, Vázquez G, Vilapriño JJ, Vilapriño M, Waisman Campos M, Grasso V, Cetkovich-Bakmas M. First Argentine Consensus Statement on the Management of Schizophrenia. Section I: Intro-duction and General Concepts. Vertex 2025; 36(169): 70-96. https://doi.org/10.53680/vertex.v36i169.900

Alcalde R, Leiva M, Cailly L, Quintero L, Plaza N, Leiva S, Cortenova C, Serapio C, Vilamani Z, Agüero M, Ledesma P, Ponce N, Guajardo R, Chaira E, Ojeda J, Vilapriño JJ, Vazquez G. Ketamina intravenosa en depresión resistente: experiencia clínica en un hospital monovalente psiquiátrico de Mendoza, Argentina. Revista LatinoAmericana de Psiquiatria 2025; 24(3): 9-16

Books and Book Chapters

“Unmet needs in Bipolar Depression” In New Directions in Psychiatry. Maurizio Pompili, Roger McIntyre, Andrea Fiorillo, Norman Sartorius (editors). Co-authors: Ross Baldessarini and Leonardo Tondo. Springer Press, New York, 2020

“The microbiota-gut-brain axis in bipolar disorder”. In The Neurobiology of Bipolar Disorder- Road to Novel Therapeutics” Eduard Vieta, Andre Carvalho and Joao Quevedo (editors). Co-authors: Susana Gomes-da-Costa, Estela Salagre, Sebastian Camino, and Iria Grande. Elsevier, Amsterdam, 2020.

“Ketamine for Treatment Resistant Depression: Neurobiology and Applications”. Editor. Carlos Zarate Jr, Elisa Brietzke (co-editors). San Diego: Elsevier Inc./Academic Press, 2021.

“Emotional Health, from Science to Whole Being”. by Carol Dillon. Cambridge Scholars Publishing. Newcastle upon Tyne, UK, 2021. Preface.

“On the Mixed States of Manic-Depressive Insanity: A Contribution to Clinical Psychiatry” by Wilhelm Weygand. Marcelo Cetkovich, Gustavo Vazquez, Micaela Dines, Verónica Grasso, Bárbara Hofmann y Daniel Sotelo (editors). Editorial Polemos, Buenos Aires, 2025. 78 pages.

“Depressive and Bipolar Disorders. Diagnosis, Neurobiology and Therapeutic Innovations”. Gustavo Vazquez (sole author). Elsevier Inc./Academic Press. London, United Kingdom & Cambridge, United States. 2025. 282 pages.

Most significant Research Projects in the last five years (2020-2025) *

* Pharmaceutical companies funded trials excluded

Current students (PhD Candidates)

Carolina Hernandorena (PhD Candidate)

Christian Avila (PhD Candidate)

Aleks Biorac (PhD Candidate)

Zahra Abba (undergrad Health Science)

Avery Reynolds (undergrad Health Science)

Veronica Grasso (PhD Candidate)

Research Champion

Roumen V Milev, MD PhD FRCPsych FRCPC DFCPA DFAPA

Professor of Psychiatry and Psychology, Queen's University, Providence Care, Kingston, On, Canada

roumen.milev@queensu.ca

Google Scholar

Pubmed Bibliography

Milev's Mood Disorder Research Team

Student Mental Health

Research Champion

Professor Anne Duffy, MSc, MD, FRCPC
Professor of Psychiatry, Director U-Flourish Collaborative Research Centre, Visiting Professor, University of Oxford, Department of Psychiatry

Key researchers and current projects in this stream:

https://www.queensu.ca/u-flourish/

Research grants (internal and external)

U-Flourish Research is funded by competitive grants from the Canadian Institutes of Health Research, Mach-Gaensslen Foundation, Rossy Family Foundation and the McCall MacBain Foundation. U-Flourish Research has been adapted and implemented at 5 UK universities with a competitive grant from the Medical Research Council MRC-UKRI under the banner of Nurture-U (https://www.nurtureuniversity.co.uk/ )

U-Flourish Publications